Pharmacists as providers: Targeting pneumococcal vaccinations to high risk populations

Vaccine

Volumn 29, Issue 45, 2011, Pages 8073-8076

  Taitel, Michael ^a   Cohen, Ed ^a   Duncan, Ian ^a   Pegus, Cheryl ^b  

^a Walgreens Co   (United States)

^b Walgreen   (United States)

Author keywords

Coverage, Pharmacy; Influenza vaccine; Pharmacist; Pneumococcal vaccine

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL PRACTICE; COMORBIDITY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HIGH RISK POPULATION; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PHARMACIST; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; MALE; MIDDLE AGED; PHARMACISTS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION GROUPS; RISK MANAGEMENT; VACCINATION; YOUNG ADULT;

EID: 80053653604     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.08.051     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention. Active bacterial core surveillance report, emerging infections program network, Streptococcus pneumoniae; 2010. Available from: http://www.cdc.gov/abcs/reports-findings/survreports/spneu09.html.
2. Willis B.C., Ndiaye S.M., Hopkins D.P., Shefer A. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: a report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep 2005, 54:1-11.
3. Rehm S.J., Farley M.M., File T.M., Hall W.J., Hopkins R., Levine O.S., et al. Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults. Postgrad Med 2009, 121(6):101-105.
4. Lynch J.P., Zhanel G.G. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin Respir Crit Care Med 2009, 30(2):189-209.
5. Weycker D., Strutton D., Edelsberg J., Sato R., Jackson L.A. Clinical and economic burden of pneumococcal disease in older US adults. Vaccine 2010, 28(31):4955-4960.
6. Koivula I., Sten M., Leinonen M., Makela P.H. Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am J Prev Med 1997, 103(October 1 (4)):281-290.
7. Nichol K.L., Baken L., Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999, 130(5):397.
8. Kawakami K., Ohkusa Y., Kuroki R., Tanaka T., Koyama K., Harada Y., et al. Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan. Vaccine 2010, 28(October 8 (43)):7063-7069.
9. Zhou W., Pool V., Iskander J.K., English-Bullard R., Ball R., Wise R.P., et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) United States, 1991-2001. MMWR Surveill Summ 2003, 52(1):1-24.
10. Sisk J.E., Moskowitz A.J., Whang W., Lin J.D., Fedson D.S., McBean A.M., et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 1997, 278(October 22 (16)):1333-1339.
11. Huang S.S., Johnson K.M., Ray G.T., Wroe P., Lieu T.A., Moore M.R., et al. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine 2011, 29(April 18 (18)):3398-3412.
12. Smith K.J., Zimmerman R.K., Lin C.J., Nowalk M.P., Ko F.S., McEllistrem M.C., et al. Alternative strategies for adult pneumococcal polysaccharide vaccination: a cost-effectiveness analysis. Vaccine 2008, 26(March 10 (11)):1420-1431.
13. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Lexau C., Reingold A., et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000, 343(26):1917-1924.
14. U.S. Department of Health and Human Services. Healthy People 2020. U.S. Department of Health and Human Services 2011 April 1 [cited 2011 April 27]. Available from: http://www.healthypeople.gov/2020/topicsobjectives2020/default.aspx.
15. WHO Statistical Information System (WHOSIS). World Health Organization 2011 [cited 2011 April 10]. Available from: http://www.who.int/whosis/indicators/2007Immunized/en/index.html.
16. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46 (No. RR-8).
17. Klabunde C.N., Meissner H.I., Wooten K.G., Breen N., Singleton J.A. Comparing colorectal cancer screening and immunization status in older Americans. Am J Prev Med 2007, 33(1):1-8.
18. Grabenstein J.D. Pharmacists as vaccine advocates: roles in community pharmacies, nursing homes, and hospitals. Vaccine 1998, 16(18):1705-1710.
19. Westrick S.C., Watcharadamrongkun S., Mount J.K., Breland M.L. Community pharmacy involvement in vaccine distribution and administration. Vaccine 2009, 27(May 11 (21)):2858-2863.
20. Kroger AT, Sumaya CV, Pickering LK, Atkinson WL. General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention 2011 January 28 [cited 2011 April 27];60(RR02):1-60. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6002a1.htm.
21. Slobodkin D., Kitlas J., Zielske P. Opportunities not missed - systematic influenza and pneumococcal immunization in a public inner-city emergency department. Vaccine 1998, 16(November (19)):1795-1802.
22. Sokos D.R., Skledar S.J., Erwin K.A., Nowalk M.P., Zimmerman R.K., Fox D.E., et al. Designing and implementing a hospital-based vaccine standing orders program. Am J Health Syst Pharm 2007, 64(May 15 (10)):1096-1102.
23. Rees S., Stevens L., Drayton J., Engledow N., Sanders J. Improving inpatient pneumococcal and influenza vaccination rates. J Nurs Care Qual 2011, 10.1097/NCQ.0b013e31821b6bb.
24. Loughlin S.M., Mortazavi A., Garey K.W., Rice G.K., Birtcher K.K. Pharmacist-managed vaccination program increased influenza vaccination rates in cardiovascular patients enrolled in a secondary prevention lipid clinic. Pharmacotherapy 2007, 27(5):729-733.
25. Yuksel N., Majumdar S.R., Biggs C., Tsuyuki R.T. Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial. Osteoporos Int 2010, 21(3):391-398.
26. Kaplan V., Angus D.C., Griffin M.F., Clermont G., Watson R.S., Linde-Zwirble W.T. Hospitalized community-acquired pneumonia in the elderly. Age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 2002, 165(March 15 (6)):766-772.
27. Vila-Corcoles A., Ochoa-Gondar O., Rodriguez-Blanco T., Raga-Luria X., Gomez-Bertomeu F. Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir Med 2009, 103(February 1 (2)):309-316.
28. Bodenheimer T. Coordinating care - a perilous journey through the health care system. N Engl J Med 2008, 358(10):1064-1071.
29. American Society of Health-System Pharmacists ASHP statement on the pharmacist's role in primary care. Am J Health-Syst Pharm 1999, 56:1665-1667.
30. Cutler D.M., Everett W. Thinking outside the pillbox: medication adherence as a priority for health care reform. N Engl J Med 2010, 362(17):1553-1555.
31. Scott M.A., Hitch B., Ray L., Colvin G. Integration of pharmacists into a patient-centered medical home. J Am Pharm Assoc 2011, 51(2):161-166.